The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma

dc.contributor.authorLewinska, Monika
dc.contributor.authorSantos-Laso, Alvaro
dc.contributor.authorArretxe, Enara
dc.contributor.authorAlonso, Cristina
dc.contributor.authorZhuravleva, Ekaterina
dc.contributor.authorJimenez-Aguero, Raul
dc.contributor.authorEizaguirre, Emma
dc.contributor.authorJesus Pareja, Maria
dc.contributor.authorRomero-Gomez, Manuel
dc.contributor.authorArrese, Marco
dc.contributor.authorSuppli, Malte P.
dc.contributor.authorKnop, Filip K.
dc.contributor.authorOversoe, Stine Karlsen
dc.contributor.authorVilladsen, Gerda Elisabeth
dc.contributor.authorDecaens, Thomas
dc.contributor.authorCarrilho, Flair Jose
dc.contributor.authorde Oliveira, Claudia P. M. S.
dc.contributor.authorSangro, Bruno
dc.contributor.authorMacias, Rocio I. R.
dc.contributor.authorBanales, Jesus M.
dc.contributor.authorAndersen, Jesper B.
dc.contributor.authoraffiliation[Lewinska, Monika] Univ Copenhagen, Biotech Res & Innovat Ctr, Dept Hlth & Med Sci, Copenhagen, Denmark
dc.contributor.authoraffiliation[Zhuravleva, Ekaterina] Univ Copenhagen, Biotech Res & Innovat Ctr, Dept Hlth & Med Sci, Copenhagen, Denmark
dc.contributor.authoraffiliation[Andersen, Jesper B.] Univ Copenhagen, Biotech Res & Innovat Ctr, Dept Hlth & Med Sci, Copenhagen, Denmark
dc.contributor.authoraffiliation[Santos-Laso, Alvaro] Univ Basque Country, UPV EHU, Donostia Univ Hosp, Dept Liver & Gastrointestinal Dis,Biodonostia Hlt, San Sebastian, Spain
dc.contributor.authoraffiliation[Jimenez-Aguero, Raul] Univ Basque Country, UPV EHU, Donostia Univ Hosp, Dept Liver & Gastrointestinal Dis,Biodonostia Hlt, San Sebastian, Spain
dc.contributor.authoraffiliation[Eizaguirre, Emma] Univ Basque Country, UPV EHU, Donostia Univ Hosp, Dept Liver & Gastrointestinal Dis,Biodonostia Hlt, San Sebastian, Spain
dc.contributor.authoraffiliation[Banales, Jesus M.] Univ Basque Country, UPV EHU, Donostia Univ Hosp, Dept Liver & Gastrointestinal Dis,Biodonostia Hlt, San Sebastian, Spain
dc.contributor.authoraffiliation[Arretxe, Enara] OWL Metabol, Derio, Spain
dc.contributor.authoraffiliation[Alonso, Cristina] OWL Metabol, Derio, Spain
dc.contributor.authoraffiliation[Jesus Pareja, Maria] Hosp Juan Ramon Jimenez Huelva, Huelva, Spain
dc.contributor.authoraffiliation[Romero-Gomez, Manuel] Univ Seville, UCM Digest Dis, Virgen del Rocio Univ Hosp, SeLiver Grp,Inst Biomed Seville IBIS, Seville, Spain
dc.contributor.authoraffiliation[Romero-Gomez, Manuel] Carlos III Natl Inst Hlth, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid, Spain
dc.contributor.authoraffiliation[Sangro, Bruno] Carlos III Natl Inst Hlth, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid, Spain
dc.contributor.authoraffiliation[Macias, Rocio I. R.] Carlos III Natl Inst Hlth, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid, Spain
dc.contributor.authoraffiliation[Banales, Jesus M.] Carlos III Natl Inst Hlth, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid, Spain
dc.contributor.authoraffiliation[Arrese, Marco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Escuela Med, Dept Gastroenterol,Ctr Envejecimiento & Regenerat, Santiago, Chile
dc.contributor.authoraffiliation[Suppli, Malte P.] Univ Copenhagen, Gentofte Hosp, Ctr Clin Metab Res, Hellerup, Denmark
dc.contributor.authoraffiliation[Knop, Filip K.] Univ Copenhagen, Gentofte Hosp, Ctr Clin Metab Res, Hellerup, Denmark
dc.contributor.authoraffiliation[Knop, Filip K.] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
dc.contributor.authoraffiliation[Oversoe, Stine Karlsen] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark
dc.contributor.authoraffiliation[Villadsen, Gerda Elisabeth] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark
dc.contributor.authoraffiliation[Decaens, Thomas] Univ Grenoble Alpes, Grenoble, France
dc.contributor.authoraffiliation[Decaens, Thomas] CHU Grenoble Alpes, Dept Hepatol & Gastroenterol, Grenoble, France
dc.contributor.authoraffiliation[Carrilho, Flair Jose] Univ Sao Paulo, Dept Gastroenterol, Fac Med, Sao Paulo, Brazil
dc.contributor.authoraffiliation[de Oliveira, Claudia P. M. S.] Univ Sao Paulo, Dept Gastroenterol, Fac Med, Sao Paulo, Brazil
dc.contributor.authoraffiliation[Sangro, Bruno] Clin Univ Navarra IDISNA, Liver Unit, Pamplona, Spain
dc.contributor.authoraffiliation[Sangro, Bruno] CIBEREHD, Pamplona, Spain
dc.contributor.authoraffiliation[Macias, Rocio I. R.] Univ Salamanca, IBSAL, Expt Hepatol & Drug Targeting HEVEPHARM Grp, Salamanca, Spain
dc.contributor.authoraffiliation[Banales, Jesus M.] IKERBASQUE, Basque Fdn Sci, Bilbao, Spain
dc.contributor.funderNovo Nordisk Foundation
dc.contributor.funderDanish Cancer Society
dc.contributor.funderDanish Medical Research Council
dc.contributor.funderSpanish Ministry of Economy and Competitiveness
dc.contributor.funder'Instituto de Salud Carlos III' grants - 'Fondo Europeo de Desarrollo Regional' (FEDER)
dc.contributor.funderCIBERehd, Spain
dc.contributor.funderIKERBASQUE, Basque foundation for Science, Spain
dc.contributor.funderBIOEF
dc.contributor.funderDepartment of Health of the Basque Country
dc.contributor.funderEuskadi RIS3
dc.contributor.funderDepartment of Industry of the Basque Country
dc.contributor.funderAECC Scientific Foundation
dc.contributor.funderEuropean Commission Horizon 2020 program (ESCALON project)
dc.contributor.funderFondo Nacional De Ciencia y Tecnologia de Chile (FONDECYT)
dc.contributor.funderComision Nacional de Investigacion, Ciencia y Tecnologia (CONICYT)
dc.date.accessioned2025-01-07T14:36:31Z
dc.date.available2025-01-07T14:36:31Z
dc.date.issued2021-10-29
dc.description.abstractBackground: Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic liver and thus, often lack clinical surveillance. The aim of this study was to develop non-invasive surveillance method for NAFLD-HCC.Methods: Using comprehensive ultra-high-performance liquid chromatography mass-spectrometry, we investigated 1,295 metabolites in serum from 249 patients. Area under the receiver operating characteristic curve was calculated for all detected metabolites and used to establish their diagnostic potential. Logistic regression analysis was used to establish the diagnostic score.Findings: We show that NAFLD-HCC is characterised by a complete rearrangement of the serum lipidome, which distinguishes NAFLD-HCC from non-cancerous individuals and other HCC patients. We used machine learning to build a diagnostic model for NAFLD-HCC. We quantified predictive metabolites and developed the NAFLD-HCC Diagnostic Score (NHDS), presenting superior diagnostic potential compared to alpha-fetoprotein (AFP). Patients' metabolic landscapes show a progressive depletion in unsaturated fatty acids and acylcarnitines during transformation. Upregulation of fatty acid transporters in NAFLD-HCC tumours contribute to fatty acid depletion in the serum.Interpretation: NAFLD-HCC patients can be efficiently distinguished by serum metabolic alterations from the healthy population and from HCC patients related to other aetiologies (alcohol and viral hepatitis). Our model can be used for non-invasive surveillance of individuals with metabolic syndrome(s), allowing for early detection of NAFLD-HCC. Therefore, serum metabolomics may provide valuable insight to monitor patients at risk, including morbidly obese, diabetics, and NAFLD patients. (C) 2021 The Author(s). Published by Elsevier B.V.
dc.identifier.doi10.1016/j.ebiom.2021.103661
dc.identifier.issn2352-3964
dc.identifier.pmid34740106
dc.identifier.unpaywallURLhttp://www.thelancet.com/article/S2352396421004552/pdf
dc.identifier.urihttps://hdl.handle.net/10668/26530
dc.identifier.wosID721615900011
dc.journal.titleEbiomedicine
dc.journal.titleabbreviationEbiomedicine
dc.language.isoen
dc.organizationSAS - Hospital Universitario Juan Ramón Jiménez
dc.publisherElsevier
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectNAFLD
dc.subjectHCC
dc.subjectmetabolomics
dc.subjectlipidomics
dc.subjectbiomarker discovery
dc.subjectDisease
dc.subjectObesity
dc.titleThe altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number73
dc.wostypeArticle

Files